a Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430; b Department of Clinical Investigation, US Naval Medical Research Unit No. 3, PSC 452, Box 5000, FPO AE 09835; c Central Research Division, Pfizer, Inc., Eastern Point Road, Groton, CT 06340 USA; d Bureau of Microbiology, HPB Bld 7, Locator 0701F1, Ottawa, Canada KIA 0L2
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Disc diffusion tests, sometimes showing indistinct zones with trailing of light growth toward discs, suggest that concentrations of azithromycin near the MIC cause partial inhibition of bacterial growth.1 Azalide antibiotics have optimal activity at pH 8.0,6 suggesting that MICs obtained in MuellerHinton broth at pH 7.2 could underestimate the antibiotic activity that may be attained in patients during treatment. Furthermore, the inoculum size of 5 x 105 bacteria per mL used in standard MIC tests is greater than the counts of viable S. typhi, which were reported as 9 x 102 per mL of blood in patients with typhoid fever.7,8 The following experiments to modify in vitro conditions of susceptibility testing were undertaken to simulate more closely the environment in infected patients.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For growth and killing curves, bacteria were grown in trypticase soy broth for 24 h to reach log phase growth. Tubes of cation-adjusted MuellerHinton broth (Difco), supplemented to give final concentrations of calcium 2025 mg/L and magnesium 1012.5 mg/L according to National Committee for Clinical Laboratory Standards (NCCLS),9 were inoculated with bacteria at a concentration of 104105 bacteria per mL. Azithromycin (Lot no. 25381-34-21) was obtained from Pfizer, Inc. and dissolved in ethanol. Two-fold dilutions of azithromycin from 1 to 16 mg/L were prepared in broth. Tubes were incubated at 37°C, and at 2, 4, 8, 24 and 48 h of incubation, aliquots were removed, diluted and plated on to MacConkey agar (BBL, Cockeysville, MD, USA) for colony counts.
Buffered solutions of MuellerHinton broth were prepared using 0.2 M disodium phosphate (Sigma Chemical Company, St Louis, MO, USA) and 0.1 M citric acid (Fisher Scientific, Fair Lawn, NJ, USA) to obtain broth at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0 and 8.5. Tris-buffered MuellerHinton broths were prepared by mixing 0.1 M solutions of Trizma hydrochloride and Trizma base (Sigma), and adjusting the pH after dissolving broth in buffered solutions. Tubes were inoculated with 105 bacteria per mL and MICs read at 24 h. Antibiotics (Sigma) were prepared by dissolving ciprofloxacin hydrochloride in water, chloramphenicol in ethanol and ampicillin sodium salt in water. In experiments to investigate inoculum effects, bacteria were grown for 46 h in trypticase soy broth at 37°C to reach turbidity estimated at >2 x 108 per mL. Serial 10-fold dilutions in cation-adjusted MuellerHinton broth were carried out for the inoculation of tubes containing azithromycin. Numbers of bacteria were determined from the 104 dilution plated on MacConkey agar.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Zones of inhibition around discs containing 15 µg azithromycin had indistinct boundaries, with growth occurring closer to the disc along linear streaks of heavier growth, which corresponded to the paths of the cotton swabs that streaked the inoculum, indicating that a heavier inoculum required a greater concentration of antibiotic to inhibit growth. When plates were allowed to incubate for 48 h, a ring of lighter growth occurred with a smaller diameter of inhibition than the outer zone of inhibition that had formed at 24 h. The rings indicated that bacteria were growing slowly at antibiotic concentrations that were just adequate to inhibit initial growth.
Growth curves
Determinations at 2, 4, 8, 24 and 48 h after inoculation showed that the sub-MIC of 2 mg/L produced inhibition at 28 h, leading to growth to turbidity at 24 h (Figure). In azithromycin 4 mg/L, growth was inhibited completely for up to 8 h of incubation, with a delay in growth to turbidity for some strains at 24 h, and for all at 48 h. For those strains that manifested turbidity at 24 h, the turbidity was less in the tubes with 4 mg/L than in control tubes without antibiotic. Likewise, at 48 h the tubes with 4 mg/L showed less turbidity than tubes with 0, 1 and 2 mg/L. Numbers of bacteria in these turbid tubes containing 4 mg/L were <107/ml and were c. 10- to 100-fold less than in control tubes without antibiotic. Tubes with 8 and 16 mg/L showed bacteriostasis at 28 h post-exposure and some killing of bacteria at 24 and 48 h, with reductions in cfu of 12 logs.
|
To examine whether the delayed growth of S. typhi was caused by the growth of azithromycin-resistant mutants, MICs were performed on cultures of S. typhi that showed turbid growth after 48 h in the presence of 4 mg/L of azithromycin. Five strains with MICs of 4 or 8 mg/L had the same MIC after exposure to 4 mg/L, and one strain with an MIC of 4 mg/L had an MIC of 8 mg/L after exposure to azithromycin, indicating that antibiotic resistance had not developed.
Bacterial morphology after exposure to azithromycin
Gram-stained slides prepared from tubes incubated for 24 and 48 h with azithromycin at concentrations of 1, 2 and 4 mg/L showed elongated and curved bacilli. Cultures with azithromycin 4 mg/L incubated for 24 or 48 h showed the greatest proportions of elongated and curved bacilli.
Effect of pH on the MIC of azithromycin
Strains of S. typhi tested in MuellerHinton broth supplemented with phosphate-citrate buffers showed reductions in MICs with increases in pH. The median MIC decreased stepwise from 64 mg/L at pH 6 to 0.13 mg/L at pH 8.5. Tris-buffered MuellerHinton broth gave results similar to those of the phosphate-citrate buffers. Median MICs of azithromycin for four strains of S. typhi were 8 mg/L (pH 6.5), 2 mg/L (pH 7.0), 0.5 mg/L (pH 7.5) and 0.13 mg/L (pH 8.0). To investigate whether the increased osmolarity of the buffered broth solutions contributed to the greater antibacterial activity of azithromycin at higher pH, broths supplemented with sodium chloride solutions (0.15 and 0.3 M NaCl) were examined. MICs for two strains of S. typhi were 8 mg/L in standard MuellerHinton broth and 16 mg/L in the broths containing NaCl, indicating that the increased osmolarity resulted in increases in the MIC of azithromycin and could not explain the lower MICs obtained at alkaline pHs.
To examine whether a lower MIC at alkaline pH is a special property of azithromycin, MICs of ciprofloxacin, ampicillin and chloramphenicol for S. typhi were tested in buffered solutions of MuellerHinton broth. Decreases in MICs from pH 6 to pH 8 were 256-fold for azithromycin, 11-fold for ciprofloxacin, three-fold for ampicillin and 1.5-fold for chloramphenicol.
Effects of divalent cations on the MIC of azithromycin
To test the effects of the addition of calcium and magnesium to concentrations of 24 and 12 mg/L, respectively, as recommended by the NCCLS, MuellerHinton broth was used with and without the addition of cations. The results indicated that the addition of calcium and magnesium, either alone or in combination, caused four-fold increases in MIC in MuellerHinton broth and two- to four-fold increases in MIC in Tris-buffered MuellerHinton broth.
Effect of inoculum size on MIC
The testing of 10-fold increments in inoculum size from c. 101 to 106 per mL for six S. typhi strains showed a corresponding increase in MIC (Table). A four-fold increase in MIC was observed when the inoculum size was increased from 103 to 105 per mL in cation-adjusted MuellerHinton broth. To test whether an inoculum effect would affect MICs in broth at alkaline pH, inoculum sizes from 106 to 10 per mL were placed into buffered MuellerHinton broth at pH 7.5. An MIC as low as 0.13 mg/L was obtained with an inoculum of 10 organisms per mL (Table
).
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The earlier observation that azithromycin in agar diffusion susceptibility tests resulted in indistinct zones of inhibition around discs, with trailing of light growth toward discs, and the finding of transitional light-growth tubes between clear and turbid tubes in two-fold series of dilution for MIC determinations1 suggested that azithromycin, at sub-MIC concentrations, would show partial inhibition of bacterial growth. Growth curves demonstrated early inhibition of growth with 2 mg/L at 2, 4 and 8 h post-exposure. At the transitional MIC of 4 mg/L, growth was inhibited at 8 h, with turbidity developing at 24 h for some strains and for all strains at 48 h. Delayed growth to turbidity in the presence of 4 mg/L of antibiotic was not caused by the emergence of resistance or by loss of antibiotic activity during incubation, and was associated with development of elongated bacilli. These elongated forms suggest that azithromycin at sub-MIC concentrations might prevent septation in the later stages of cell division. The elongated bacterial forms explain the lower colony counts obtained in turbid broths containing 4 mg/L than in broth without antibiotic at 24 and 48 h of incubation because the elongated bacteria would produce fewer colonies relative to bacterial mass while still contributing to the turbidity of the broth. Assuming that the elongated bacteria remain viable, each would produce one colony when subcultured to solid media.
The mechanism of the effect of pH is likely to be greater transport of azithromycin into bacterial cells or greater access to ribosomal attachment sites at alkaline pH. The pH effect appeared not to occur by direct action on the bacterium because little or no effect on the MIC was observed with chloramphenicol and ampicillin. With ciprofloxacin, there was a decrease in MIC at alkaline pH, but the effect was much less than with azithromycin. Calcium and magnesium ions may play a role in the pH effect because the latter was partially abrogated in the presence of increased concentrations of divalent cations.
An inoculum effect of macrolide antibiotics against staphylococci and streptococci has also been reported. This may explain the range of MICs of 416 mg/L for S. typhi reported by Metchock3 and the difficulty we reported in reading zones of inhibition in disc diffusion,1 as well as the streaks of heavier inoculum extending closer to the discs that occurred in these experiments.
![]() |
Acknowledgments |
---|
![]() |
Notes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2
.
Girgis, M. I., Butler, T., Frenck, R. W., Sultan, Y., Brown, F. M., Tribble, D. et al. (1999). Azithromycin versus ciprofloxacin for the treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrobial Agents and Chemotherapy 43, 14414.
3 . Metchock, B. (1990). In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 2931.[Abstract]
4 . Retsema, J., Girard, A., Schelky, W., Manousos, M., Anderson, M. & Bright, G. (1987). Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy 31, 193947.[ISI][Medline]
5 . Wildfeuer, A., Laufen, H. & Zimmerman, T. (1996). Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrobial Agents and Chemotherapy 40, 759.[Abstract]
6 . Carbon, C. (1998). Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. Clinical Infectious Diseases 27, 2832.[ISI][Medline]
7 . Butler, T., Bell, W. R., Levin, J., Linh, N. N. & Arnold, K. (1978). Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Archives of Internal Medicine 138, 40710.[Abstract]
8
.
Wain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Hoa, N. T. T., Parry, C. M. et al. (1998). Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. Journal of Clinical Microbiology 36, 16837.
9 . National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A4. NCCLS, Wayne, PA.
Received 2 May 2000; returned 3 August 2000; accepted 6 December 2000